Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
10/2005
10/06/2005WO2005092836A1 Opioid receptor antagonists
10/06/2005WO2005092835A1 Pharmaceutical compounds
10/06/2005WO2005092833A1 Process for producing 1,2-ethanediamine derivative
10/06/2005WO2005092317A1 Thyroid receptor agonists
10/06/2005WO2005091754A2 Novel cyclopentenedione antifungal compounds and methods for their use
10/06/2005WO2005058796A3 Processes for preparing venlafaxine and venlafaxine hydrochloride of form i
10/06/2005CA2562633A1 Thyroid receptor agonists
10/06/2005CA2560931A1 Novel cyclopentenedione antifungal compounds and methods for their use
10/06/2005CA2557794A1 Opioid receptor antagonists
10/05/2005EP1581201A1 Method for producing sterile polynucleotide based medicaments
10/05/2005EP1226107B1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives
10/05/2005CN1679200A Nonaqueous electrolyte and nonaqueous-electrolyte secondary battery
10/05/2005CN1678654A Polyether polyamine agents and mixtures therefor
10/05/2005CN1678395A Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions
10/05/2005CN1676513A Novel anti-hypertension chemical entity (TMEP)
10/05/2005CN1221524C Diphenyl ether compounds useful in therapy
10/04/2005US6951961 Methods of use and compositions for the diagnosis and treatment of infectious disease
10/04/2005US6951574 Primary intermediates for oxidative coloration of hair
09/2005
09/29/2005WO2005090283A1 Methods of amination
09/29/2005US20050215821 reacting 2-[(dimethylamino)methyl]-cyclohexanone in a Grignard reaction with a Grignard compound of 3-bromoanisole in a suitable solvent and in the presence of an inorganic lithium salt and an alpha , omega -dialkoxyalkane; high stereoselectivity and high yield
09/29/2005US20050215811 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215648 Oxymethylidene-substituted, e.g., 2-(1-methoxy-ethylidene)-cyclopent-4-ene-1,3-diones; inhibit fluconazole-resistant C. albicans strains; may be used for the treatment of life-threatening candidiasis associated with immunocompromised patients.
09/29/2005US20050215590 Formamide derivatives for the treatment of diseases
09/29/2005US20050214952 Oligo(p-phenylene vinylene) amphiphiles and methods for self-assembly
09/28/2005EP1580185A1 Secondary n-Alkylhydroxylated p-Phenylendiamins, dye composition for keratin fibers containing them, processes and uses.
09/28/2005EP1580184A1 secondary N-alkylepolyhydroxilated p-phenylendiamines, dye composition comprising them, processes and uses
09/28/2005EP1578898A2 Nad synthetase inhibitors and uses thereof
09/28/2005EP1578715A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
09/28/2005EP1578353A2 Methods of use and compositions for the diagnosis and treatment of infectious disease
09/28/2005CN1675168A Propionic acid derivatives and their use as hPPARs activators
09/28/2005CN1675167A Process for preparing 2-[(dimethylamino)-methyl]-1-(3-methoxyphenyl)cyclohexanol
09/28/2005CN1675145A Method of deuterating aromatic ring
09/28/2005CN1673219A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
09/28/2005CN1673214A Imine analogs of meglumine iothalamate compounds and their synthesis process
09/27/2005US6949669 Organic compounds
09/27/2005US6949568 Such as N-(2-(4-(3-phenyl-4-methoxyphenyl)aminophenyl)ethyl)-2-hydroxy-2-(3 -hydroxymethyl-4-hydroxyphenyl)ethylamine; for treatment of chronic obstructive pulmonary disease
09/27/2005CA2193337C 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
09/22/2005WO2005087700A2 Bisphenyl compounds useful as vitamin d3 receptor agonists
09/22/2005US20050209462 Synthesis of benzimidate from benzoic acid
09/22/2005US20050209341 R-(-)-N-methyl 3-((2-methyl-4-hydroxyphenyl)oxy)-3-phenyl-1-aminopropane or its hydrochloride salt; inhibiting the uptake of norepinephrine and serotonin; antidepressants, analgesics; treating sleep disorders, autism, psychological disorders, eating disorders
09/22/2005US20050209275 Beta 2-adrenergic receptor agonists
09/22/2005US20050208402 Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus
09/21/2005EP1577288A1 Selective estrogen receptor modulators
09/21/2005EP1575922A1 Biphenyl derivatives and their use as fungicides
09/21/2005EP1575495A2 Compounds and methods
09/21/2005CN1671651A N-bisaryl- and N-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
09/21/2005CN1671647A Optically active 1-(fluoro-, trifluoromethyl-or trifluoromethoxy-substituted phenyl) alkylamine n-monoalkyl derivatives and process for producing same
09/21/2005CN1671646A Preparation of secondary amines
09/21/2005CN1671639A Novel biphenyl and biphenyl-like cannabinoids
09/20/2005US6946560 Ligands for metals and improved metal-catalyzed processes based thereon
09/20/2005US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/15/2005WO2005085176A1 π-CONJUGATED AROMATIC RING-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE
09/15/2005WO2005049560A3 Process for the preparation of anti-depressant compound
09/15/2005US20050203301 Processes for producing 7-isoindoline-quinolone carboxylic acid derivative and its intermediate, as well as salt of 7-isoindoline-quinolonecarboxylic acid derivative, its hydrate and composition comprising the same as active ingredient
09/14/2005EP1574562A1 Detergent compositions
09/14/2005EP1574498A1 Process for the synthesis of substituted alpha-aminoindan derivatives
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1250317B1 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
09/14/2005CN1668703A Charge transport compositions on the basis of triarylmethanes and their use in electronic devices
09/14/2005CN1668616A Charge transport compositions comprising fluorizated quinazoline derivatives
09/14/2005CN1668572A Intermediate in producing phenoxyacetic acid derivatives and method for using same
09/13/2005US6943194 oxidizing 3-(tert-butyl dimethylsilyl)oxy-4-methoxybenzaldehyde with potassium permanganate to form carboxylic acid, converting to corresponding acid chloride, protecting with a butyllithium derivative, deprotecting to form phenstatin
09/13/2005US6943193 administering to the male or femal patients with sexual disorders a therapeutically effective amount of atomoxetine or a pharmaceutically acceptable salt
09/13/2005US6943184 For therapy of Alzheimer's disease, Parkinson's disease, Pick's disease, Korsakoff s disease cerebral ageing, of mood disorders, of pain and of tobacco withdrawal
09/13/2005CA2137406C Process for key intermediates for hiv protease inhibitors
09/09/2005WO2005082838A1 New process for the synthesis of substituted alpha -aminoindan derivatives
09/09/2005WO2005082837A1 Synthesis of sterically hindered secondary aminoether alcohols from acid anhydride and/or acid halide and sulfur trioxide
09/09/2005WO2005082835A1 Synthesis of sterically hindered secondary aminoether alcohols
09/09/2005WO2005082834A1 Catalytic preparation of severely sterically hindered amino-ether alcohols using a metal loaded catalyst
09/09/2005WO2005082824A1 Method for the preparation of aryl ethers
09/09/2005WO2005081778A2 Improved synthesis of severely sterically hindered amino-ether alcohols and diaminopolyalkenyl ethers using a high activity powder catalyst
09/09/2005WO2004064762A3 Novel cocrystallization
09/09/2005CA2556063A1 Method for the preparation of aryl ethers
09/08/2005US20050197482 for production of polyimides; for complexing with epoxy resin/silicone resin; photosensitivity
09/08/2005US20050197392 O-desmethylvenlafaxine and methods of preparing and using the same
09/08/2005US20050197383 Quaternary ammonium compounds and their use as anti-tussive agents
09/08/2005US20050194113 Synthetic multiple quaternary ammonium salts
09/07/2005EP1571140A1 C-substituted cyclohexylmethylamine derivatives
09/07/2005EP1569892A2 Calcilytic compounds
09/07/2005CN1666577A Electronic devices made with electron transport and/or anti-quenching layers
09/07/2005CN1666357A Polymeric charge transport compositions and electronic devices made with such compositions
09/07/2005CN1665824A Substituted aryl boronic acids, their preparation and their precursors
09/07/2005CN1665801A Anti tubercular drug: compositions and methods
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1217918C Aminocyclohexyl ether compounds and uses thereof
09/07/2005CN1217917C Laundry detergent compositions comprising hydrophobically modified polyamines
09/07/2005CN1217903C Substituted biphenyl oxazoline
09/06/2005USRE38793 dibenzylation of the amino group of alpha-alanine methyl ester, reduction to the N,N-dibenzylamino alcohol, then oxidation to form aldehyde, reaction with grignard reagent to form an intermediate, deprotecing by catalytic hydrogenation
09/06/2005US6939986 From 1,2-epoxides; useful as inhibitors of viral or bacterial neuraminidases
09/06/2005US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine,
09/01/2005WO2005079774A2 Management of ophthalmologic disorders, including macular degeneration
09/01/2005WO2005068403A3 Method for selective reduction of aromatic compounds
09/01/2005US20050192316 Aryl aniline beta2 adrenergic receptor agonists
09/01/2005US20050192208 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators ; potassium channel moderators; prevent fibrillation
09/01/2005CA2555261A1 Management of ophthalmologic disorders, including macular degeneration
08/2005
08/31/2005EP1568686A1 n-alkylaminated secondary paraphenylendiamine, which is ortho- and/or meta-substituted, dying composition comprising this paraphenylendiamine, methods based on this composition and uses
08/31/2005EP1568684A1 para-phenylenediamines carrying an alkoxy group, dye composition, preparation methods and their use
08/31/2005EP1568683A2 Secondary, N-alkylaminated para-phenylenediamines, compositions for dyeing keratinic fibres containing them, processes using this compositions and uses thereof
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 140